scholarly journals The New Orleans Alcohol Use in HIV Study : Launching a Translational Investigation of the Interaction of Alcohol Use with Biological and Socioenvironmental Risk Factors for Multimorbidity in People Living with HIV

2019 ◽  
Vol 43 (4) ◽  
pp. 704-709 ◽  
Author(s):  
David A. Welsh ◽  
Tekeda Ferguson ◽  
Katherine P. Theall ◽  
Liz Simon ◽  
Angela Amedee ◽  
...  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Cláudio Moss da Silva ◽  
Raúl Andrés Mendoza-Sassi ◽  
Luisa Dias da Mota ◽  
Maíba Mikhael Nader ◽  
Ana Maria Barral de Martinez

2020 ◽  
Vol 44 (6) ◽  
pp. 1261-1272 ◽  
Author(s):  
Tekeda F. Ferguson ◽  
Katherine P. Theall ◽  
Meghan Brashear ◽  
Vincent Maffei ◽  
Alaina Beauchamp ◽  
...  

2019 ◽  
Vol 96 (6) ◽  
pp. 878-888 ◽  
Author(s):  
Erica A. Felker-Kantor ◽  
Maeve E. Wallace ◽  
Aubrey Spriggs Madkour ◽  
Dustin T. Duncan ◽  
Katherine Andrinopoulos ◽  
...  

2019 ◽  
Vol 55 (1) ◽  
pp. 28-36 ◽  
Author(s):  
Tekeda F Ferguson ◽  
Erika Rosen ◽  
Rotonya Carr ◽  
Meghan Brashear ◽  
Liz Simon ◽  
...  

Abstract Aim This cross-sectional analysis of the New Orleans Alcohol Use in HIV (NOAH) study assesses whether current and lifetime alcohol use in people living with HIV (PLWH) are associated with greater liver disease and how hepatitis C-viral (HCV) co-infection (HIV/HCV+) modifies the association. Methods Alcohol use was measured by Lifetime Drinking History (LDH), a 30-day Timeline Followback calendar, the Alcohol Use Disorder Identification Test, and phosphatidylethanol. Liver disease was estimated by alanine aminotransferase (ALT), aspartate aminotransferase (AST), AST platelet ratio-index (APRI), fibrosis-4 index (FIB-4) and nonalcoholic fatty liver disease-fibrosis score. Associations between alcohol consumption and liver disease were estimated with multivariable logistic regression. Models were adjusted for age, sex, body-mass index, hepatitis B and HIV viral load. Results Participants (N = 353) were majority male (69%) and black (84%) with a mean age of 48.3 ± 10 years. LDH was significantly associated with advanced liver fibrosis (FIB-4 aOR = 22.22 [1.22–403.72]) only among HIV/HCV+ participants with an LDH of 100–600 kg. HIV/HCV+ participants had a higher prevalence of intermediate and advanced liver disease markers than HIV/HCV− (P < 0.0001). Advanced markers of liver disease were most strongly associated with hazardous drinking (≥40(women)/60(men) grams/day) (APRI aOR = 15.87 (3.22–78.12); FIB-4 aOR = 6.76 (1.81–7.16)) and PEth ≥400 ng/ml (APRI aOR = 17.52 (2.55–120.54); FIB-4 aOR = 17.75 (3.30–95.630). Conclusion Results indicate a greater association of current alcohol use with liver disease than lifetime alcohol use, which varied by HCV status. These findings stress the importance of reducing alcohol use in PLWH to decrease risk of liver disease and fibrosis.


AIDS Care ◽  
2015 ◽  
Vol 27 (7) ◽  
pp. 844-848 ◽  
Author(s):  
Jeremy Y. Chow ◽  
Marcella Alsan ◽  
Wendy Armstrong ◽  
Carlos del Rio ◽  
Vincent C. Marconi

2021 ◽  
pp. 1-8
Author(s):  
Rebecca J. Fisk ◽  
Veronica L. Richards ◽  
Robert F. Leeman ◽  
Babette Brumback ◽  
Christa Cook ◽  
...  

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S506-S506
Author(s):  
Folusakin Ayoade ◽  
Dushyantha Jayaweera

Abstract Background The risk of ischemic stroke (IS) is known to be higher in people living with HIV (PLWH) than uninfected controls. However, information about the demographics and risk factors for hemorrhagic stroke (HS) in PLWH is scant. Specifically, very little is known about the differences in the stroke risk factors between HS and IS in PLWH. The goal of this study was to determine the demographics and risk factor differences between HS and IS in PLWH. Methods We retrospectively analyzed the demographic and clinical data of PLWH in OneFlorida (1FL) Clinical Research Consortium from October 2015 to December 2018. 1FL is a large statewide clinical research network and database which contains health information of over 15 million patients, 1240 clinical practices, and 22 hospitals. We compared HS and IS based on documented ICD 9 and 10 diagnostic codes and extracted information about sociodemographic data, traditional stroke risk factors, Charlson comorbidity scores, habits, HIV factors, diagnostic modalities and medications. Statistical significance was determined using 2-sample T-test for continuous variables and adjusted Pearson chi square for categorical variables. Odds ratio (OR) and 95% confidence intervals (CI) between groups were compared. Results Overall, from 1FL sample of 13986 people living with HIV, 574 subjects had strokes during the study period. The rate of any stroke was 18.2/1000 person-years (PYRS). The rate of IS was 10.8/1000 PYRS while the rate of HS was 3.7/1000 PYRS, corresponding to 25.4% HS of all strokes in the study. Table 1 summarizes the pertinent demographic and risk factors for HS and IS in PLWH in the study. Table 1: Summary of pertinent demographic and risk factors for hemorrhagic and ischemic strokes in people living with HIV from One Florida database Conclusion In this large Floridian health database, demographics and risk factor profile differs between HS and IS in PLWH. Younger age group is associated with HS than IS. However, hypertension, hyperlipidemia and coronary artery disease are more likely to contribute to IS than HS in PLWH. Further research is needed to better understand the interplay between known and yet unidentified risk factors that may be contributing to HS and IS in PLWH. Disclosures All Authors: No reported disclosures


Sign in / Sign up

Export Citation Format

Share Document